Global Hospital-Acquired Infection Control Market To Grow At A CAGR of 9.89% During The Forecast Period

The global hospital-acquired infection control market was valued at USD 28.99 billion in 2021. The global market is projected to grow to about USD 34.03 billion at a CAGR of 9.89% by 2028.

Patients are more susceptible to diseases when they are hospitalized because their immunity is low and medical premises are hotspots for microorganisms. HAIs can infect elder patients & young children and the most vulnerable are patients with low immunity. Some of the major factors that cause hospital-acquired infections are the use of elemental catheters, long & frequent hospital visits, improper sanitation procedures by healthcare professionals, and undue use of antibiotics.

HAI is a reason for a higher death rate than other causes like AIDS, breast cancer, or accidents. Hence it becomes imperative to curb the spread of HAIs thus propelling the global hospital-acquired infection control market growth in the coming years.

Due to the onset of Covid-19, the global market witnessed an upward trend in 2020 and 2021 owing to an increased infection rate amongst the general population. Even though hospital visits were restricted to Covid-19 patients only, the need for sterilizing medical tools was higher and strict measures were laid down by hospital management to adhere to high hygiene standards.

The global hospital-acquired infection control market is propelled by the rising number of chronic diseases and the elderly population worldwide which eventually leads to frequent hospital visits thus pushing the need to control hospital-acquired infections. During Covid-19, government and private healthcare regulatory bodies, across the globe, drafted strict protocols to upgrade the hygiene and sanitation section of medical facilities. Guidelines issued by WHO for the prevention and curbing of respiratory diseases induced by a pandemic or endemic are a live example of steps taken for controlling these infections. The guidelines are related to SOP for use of personal protective gear, protocols for sterilization & disinfection, or hand hygiene. One of the most effective ways to prevent hospital-acquired infections is the complete sterilization of medical tools since it prevents pathogen transmission from one patient to another. The utilization of reusable equipment requires that hospital facilities have technologically advanced sterilization processes or tools in action to prevent HAIs. The rising demand for sterilizing medical devices coupled with other reasons mentioned is expected to aid the global market growth.

The safety concerns related to reusable medical equipment may restrain the global market growth. The growth in the utilization of single-use equipment and the introduction of ethylene oxide as a sterilizer are expected to provide growth opportunities for global market expansion. The complexities related to the disinfection of advanced medical equipment may pose challenges in the global market.

The global hospital-acquired infection control market is segmented based on infection type, products & services, end-user, and region.

By infection type, the global market is segmented into bloodstream infections, hospital-acquired pneumonia, infections, gastrointestinal infections, surgical site, UTIs, and others. The segment is expected to be dominated by urinary tract infections.

By product & services, the global market is segmented into protective barriers, cleaning & disinfection products, sterilization, and endoscope reprocessing products. The segment may be dominated by protective barriers since they dominated the market in 2020 and have been following the same trend.

By end-user, the global market segments are ambulatory surgical centers, hospitals & clinics, and others. The segment is expected to be led by ambulatory surgical centers with the highest CAGR during the forecast period.

North America is showing signs of dominating the global hospital-acquired infection control market because of the remarkable healthcare infrastructure in regions like the USA and Canada. The governments of these regions spend hefty amounts on constantly upgrading the state of the healthcare facilities and come up with great initiatives to aid the creation of excellent medical programs and facilities. A lot of key private investors also support such government initiatives thus allowing for regional growth.

Asia-Pacific may also register high revenue in the coming years mainly due to large-scale sanitizing and disinfecting manufacturing units in regions like India and China. Europe is projected to grow significantly owing to stringent government regulations related to safety in hospitals and treatment facilities thus propelling the need for disinfecting medical tools regularly and efficiently.

Some of the major players in the global hospital-acquired infection control market are MMM Group, 3M Company, Fortive, Matachana Group, Steris Plc., Belimed AG, Ecolab Inc, Miele Group, Sotera Health LLC, Getinge AB, Reckitt Benckiser, Continental Equipment Company, and Pal International, Contec, Inc., C.B.M. S.r.l. Medical Equipment.

Recent Developments:

• In September 2021, a partnership between Sodexo and Ecolab Inc. emerged for the prevention of HAIs. The partnership has resulted in a new program called Protecta Plus which assists hospitals and medical clinics in better prevention of hospital-acquired infections in the USA.
• In November 2021, the acquisition of Regulatory Compliance Associates (RCA) by Sotera Health Company has aided the expansion of quality, technical consulting, and regulatory capabilities in the USA.

Browse the full “Hospital-Acquired Infection Control Market By Infection Type (Bloodstream Infections, Hospital Acquired Pneumonia, Infections, Gastrointestinal Infections, Surgical Site, Urinary Tract Infections (UTIs), and Others), By Product & Service (Protective Barriers, Cleaning & Disinfection Products, Sterilization, and Endoscope Reprocessing Products), By End User (Ambulatory Surgical Centers, Hospitals & Clinics, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/hospital-acquired-infection-control-market

Global hospital-acquired infection control market is segmented as below:

By Infection type

• Bloodstream Infections
• Hospital-acquired Pneumonia
• Infections
• Gastrointestinal Infections
• Surgical Site
• UTIs
• Others

By Products & Services

• Protective Barriers
• Cleaning & Disinfection Products
• Sterilization
• Endoscope Reprocessing Products

By End-user

• Surgical Centers
• Hospitals & Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com